Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Seidman

Showing results (361-370 of 533) with videos related to

Pageof 54
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2007
An Ryr1I4895T mutation abolishes Ca2+ release channel function and delays development in homozygous offspring of a mutant mouse lineElena Zvaritch, Frederic Depreux, Natasha Kraeva, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2011
Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development. [corrected]Ivan P Moskowitz, Jun Wang, Michael A Peterson, et al.
Nature Genetics|January 1, 1997
Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndromeC T Basson, D R Bachinsky, R C Lin, et al.
JACC. Heart Failure|March 14, 2014
Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathyYuichi J Shimada, Jonathan J Passeri, Aaron L Baggish, et al.
Circulation|February 6, 2002
Accelerated cardiomyopathy in mice with overexpression of cardiac G(s)alpha and a missense mutation in the alpha-myosin heavy chainStefan E Hardt, Yong-Jian Geng, Olivier Montagne, et al.
Circulation Research|April 3, 2004
Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffeningBradley M Palmer, Dimitrios Georgakopoulos, Paul M Janssen, et al.
Circulation. Cardiovascular Genetics|October 15, 2017
A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy PatientsAllison L Cirino, Neal K Lakdawala, Barbara McDonough, et al.
Public Health Genomics|January 24, 2015
A one-page summary report of genome sequencing for the healthy adultJason L Vassy, Heather M McLaughlin, Heather L McLaughlin, et al.
Circulation. Genomic and Precision Medicine|September 5, 2020
Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic CardiomyopathyAkl C Fahed, Georges Nemer, Fadi F Bitar, et al.
The Journal of Clinical Investigation|March 18, 2003
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophyQiujing Song, Albrecht G Schmidt, Harvey S Hahn, et al.
Pageof 54

Showing results (361-370 of 533) with videos related to

Sort By:
Pageof 54
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2007
An Ryr1I4895T mutation abolishes Ca2+ release channel function and delays development in homozygous offspring of a mutant mouse lineElena Zvaritch, Frederic Depreux, Natasha Kraeva, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2011
Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development. [corrected]Ivan P Moskowitz, Jun Wang, Michael A Peterson, et al.
Nature Genetics|January 1, 1997
Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndromeC T Basson, D R Bachinsky, R C Lin, et al.
JACC. Heart Failure|March 14, 2014
Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathyYuichi J Shimada, Jonathan J Passeri, Aaron L Baggish, et al.
Circulation|February 6, 2002
Accelerated cardiomyopathy in mice with overexpression of cardiac G(s)alpha and a missense mutation in the alpha-myosin heavy chainStefan E Hardt, Yong-Jian Geng, Olivier Montagne, et al.
Circulation Research|April 3, 2004
Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffeningBradley M Palmer, Dimitrios Georgakopoulos, Paul M Janssen, et al.
Circulation. Cardiovascular Genetics|October 15, 2017
A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy PatientsAllison L Cirino, Neal K Lakdawala, Barbara McDonough, et al.
Public Health Genomics|January 24, 2015
A one-page summary report of genome sequencing for the healthy adultJason L Vassy, Heather M McLaughlin, Heather L McLaughlin, et al.
Circulation. Genomic and Precision Medicine|September 5, 2020
Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic CardiomyopathyAkl C Fahed, Georges Nemer, Fadi F Bitar, et al.
The Journal of Clinical Investigation|March 18, 2003
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophyQiujing Song, Albrecht G Schmidt, Harvey S Hahn, et al.
Pageof 54